Viemed Healthcare, Inc.
VMD· Nasdaq
Released Aug 6, 2025, after the close
10-Q filed Aug 6, 2025, 37 days after period end · 0001729149-25-000119
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $63.06M | $54.97M | $43.31M | $33.31M |
| Net Income | $3.16M | $1.47M | $2.33M | $967.00K |
| EPS Diluted |
Viemed Healthcare, Inc. · CIK 1729149 · Engraved from SEC EDGAR
| $0.08 |
| $0.04 |
| $0.06 |
| $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.